Items where Author is "Cerny, T."

2017

Ess, S. M. and Herrmann, C. and Frick, H. and Krapf, M. and Cerny, T. and Jochum, W. and Früh, M.. (2017) Epidermal growth factor receptor and anaplastic lymphoma kinase testing and mutation prevalence in patients with advanced non-small cell lung cancer in Switzerland: a comprehensive evaluation of real world practices. European journal of cancer care, 26 (6). e12721.

2016

Neumair, P. and Joos, L. and Warschkow, R. and Dutly, A. and Ess, S. and Hitz, F. and Fruh, M. and Brutsche, M. and Baty, F. and Krahenbuhl, S. and Cerny, T. and Joerger, M.. (2016) Erlotinib has comparable clinical efficacy to chemotherapy in pretreated patients with advanced non-small cell lung cancer (NSCLC): A propensity-adjusted, outcomes research-based study. Lung Cancer, 100. pp. 38-44.

2014

Joerger, M. and Schaer-Thuer, C. and Koeberle, D. and Matter-Walstra, K. and Gibbons-Marsico, J. and Diem, S. and Thuerlimann, B. and Cerny, T.. (2014) Off-label use of anticancer drugs in eastern Switzerland: a population-based prospective cohort study. European Journal of Clinical Pharmacology, 70 (6). p. 719.

2013

Jürgens, V. and Ess, S. and Phuleria, H. C. and Früh, M. and Schwenkglenks, M. and Frick, H. and Cerny, T. and Vounatsou, P.. (2013) Tobacco-related cancer mortality : projections for different geographical regions in Switzerland. Swiss Medical Weekly, 143. w13771.

2010

Joerger, M. and Huitema, A. D. R. and Krähenbühl, S. and Schellens, J. H. M. and Cerny, T. and Reni, M. and Zucca, E. and Cavalli, F. and Ferreri, A. J. M.. (2010) Methotrexate area under the curve is an important outcome predictor in patients with primary CNS lymphoma : a pharmacokinetic-pharmacodynamic analysis from the IELSG no. 20 trial. British journal of cancer, Vol. 102, H. 4. pp. 673-677.

2008

Joerger, M. and Nuessli, D. F. and Henz, S. and Zaunbauer, W. and Cerny, T. and Cogliatti, S. B. and Gillessen, S.. (2008) CT-diagnosed mesenteric alterations in patients with non-Hodgkin's lymphoma: a population-based study. Onkologie, 31 (10). pp. 514-519.